Evidence map›Paper›PMID 41741816›Full record

ArticleCellular and molecular life sciences : CMLS2026

BPGM shapes NFAT5-driven cellular responses.

Kameliya Roegner, Vera A Kulow, Ralf Mrowka, Kristina Engel, Bayram Edemir, Mumtaz Kasim, Cem Erdogan, Laetitia Malotka, Michael Fähling, Robert Labes

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Kameliya Roegner *Institut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-2487-3696
Vera A Kulow *Institut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-4226-6697
Ralf MrowkaKlinik für Innere Medizin III - Experimentelle Nephrologie, Friedrich-Schiller- Universität, Universitätsklinikum Jena, Am Klinikum 1, CeTraMed F3, D-07743, Jena, Germany.ORCID http://orcid.org/0000-0002-0991-3418
Kristina EngelInnere Medizin IV (Hematology and Oncology), Martin-Luther-Universität Halle, Ernst-Grube-Straße 40, D-06120, Halle (Saale), Germany.ORCID http://orcid.org/0009-0005-0916-1614
Bayram EdemirInnere Medizin IV (Hematology and Oncology), Martin-Luther-Universität Halle, Ernst-Grube-Straße 40, D-06120, Halle (Saale), Germany.ORCID http://orcid.org/0000-0002-8573-3646
Mumtaz KasimInstitut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany.ORCID http://orcid.org/0009-0006-2687-4840
Cem ErdoganInstitut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-6319-0978
Laetitia MalotkaInstitut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany.
Michael FählingInstitut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany. michael.faehling@charite.de.ORCID http://orcid.org/0000-0003-1079-5049
Robert LabesInstitut für Translationale Physiologie (CCM), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, D-10117, Berlin, Germany.ORCID http://orcid.org/0000-0001-8179-1315

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osmotic stress represents a major challenge to cells, particularly in the kidney, where tonicity gradients are both physiologically relevant and pathologically altered. The transcription factor nuclear factor of activated T cells 5 (NFAT5) is a key regulator of the osmoadaptive response, yet its downstream metabolic effectors remain incompletely understood. In this study, we identify the glycolytic side-branch enzyme 2,3-bisphosphoglycerate mutase (BPGM) as a transcriptional NFAT5 target that is induced under hypertonic conditions. RNA-seq analysis revealed that Bpgm knockdown significantly alters gene expression under osmotic stress (450 mOsmol/kg), with substantial overlap between BPGM- and NFAT5-responsive transcriptional programs. Bpgm depletion impairs the induction of canonical NFAT5 target genes, suggesting a functional interplay between metabolic and transcriptional adaptation. Promoter enrichment analysis showed that genes regulated by both NFAT5 and BPGM under hypertonic conditions are associated with CpG islands and GC-rich elements, supporting a link to chromatin structure and transcriptional accessibility. Consistently, we show that HIF-1α expression is regulated downstream of NFAT5 and BPGM, indicating a hierarchical organization of osmotic and hypoxic stress responses. We propose that BPGM facilitates NFAT5 function through metabolic-epigenetic coupling, acting as an amplifier of protective gene expression. Notably, this axis is active in BPGM-expressing cells such as those of the distal convoluted tubule. Thus, our findings establish BPGM as a critical node in the osmoadaptive gene regulatory network and highlight how cell type-specific metabolic profiles influence the transcriptional response to hypertonic stress.

Indexed as

Transcription FactorsAnimalsGene Expression RegulationHumansHypoxia-Inducible Factor 1, alpha SubunitOsmotic PressurePromoter Regions, GeneticHypoxia-Inducible Factor 1, alpha SubunitNFAT5 protein, humanTranscription FactorsBPGMHypertonicityKidneyMetabolic-epigenetic couplingNFAT5Osmotic stress

Identifiers

PMID41741816
PMCPMC12960884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.